Danny Crichton, Head of Editorial & Riskgaming at Lux Capital, joins the podcast to break down the state of U.S. export bans on AI chips — and whether they’re actually working. Danny explains why NVIDIA is so central to the policy debate, how sales are still finding their way to China through workarounds like Singapore, and why the U.S. may not be able to stop China from achieving AI parity if their models keep catching up in performance.

We also discuss the tension between national security and commercial success, the importance of measuring output rather than input when it comes to China’s AI capabilities, and what it really means for the U.S. to "stay ahead."

Finally, we covered Klarna’s reversal on AI-only customer support, Google’s new AI Futures Fund, a biotech startup linked to Elizabeth Holmes, and Omada Health’s IPO filing.